IPD Group Limited (IPG.AX)
AUD 3.81
(0.26%)
AUD 3.81
(0.26%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 23.36 Million | 7.42 Million | 11.19 Million | 10.29 Million | 10.14 Million | 1.87 Million |
| Net Income | 22.36 Million | 16.07 Million | 11.11 Million | 6.5 Million | 3.97 Million | -224 Thousand |
| Depreciation & Amortization | 5.81 Million | 4.36 Million | 3.59 Million | 3.96 Million | 3.31 Million | 3.12 Million |
| Deferred income taxes | - | -25.88 Million | -15.37 Million | -12.54 Million | -939 Thousand | 623 Thousand |
| Stock-based compensation | - | 419 Thousand | 288 Thousand | 113 Thousand | - | - |
| Change in working capital | -6.93 Million | -13.87 Million | -5.72 Million | -987 Thousand | 3.82 Million | -1.91 Million |
| Other non-cash items | 50.29 Million | 26.31 Million | 17.29 Million | 13.24 Million | 6.79 Million | 6.51 Million |
| Investing Cash Flow | -104.85 Million | -2.1 Million | -4.11 Million | -3.47 Million | -1.71 Million | -976 Thousand |
| Investments in PPE | -1.79 Million | -2.15 Million | -1.99 Million | -668 Thousand | -605 Thousand | -1.12 Million |
| Acquisitions | -99.81 Million | 57 Thousand | -2.33 Million | -2.8 Million | -1.1 Million | 151 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -3.33 Million | 57 Thousand | 213 Thousand | 1000.00 | 52 Thousand | - |
| Financing Cash Flow | 83.01 Million | -10.02 Million | 5.81 Million | -5.89 Million | -2.77 Million | -1.4 Million |
| Debt repayment | -31.1 Million | -2.86 Million | -2.4 Million | -2.99 Million | -1.37 Million | - |
| Dividends payments | -8.82 Million | -7.16 Million | -9.3 Million | -2.9 Million | -1.4 Million | -1.4 Million |
| Common Stock Repurchased | - | - | -2.47 Million | - | - | - |
| Common Stock Issuance | 65 Million | - | 20 Million | - | - | - |
| Other Financing Activities | -4.27 Million | -2.86 Million | -2.4 Million | -2.99 Million | -1.37 Million | - |
| Accounts receivables | -25.74 Million | -7.36 Million | -10.55 Million | -10.13 Million | -2.43 Million | 81 Thousand |
| Accounts payables | 25.78 Million | 56 Thousand | 12.36 Million | 13.2 Million | 2.53 Million | -737 Thousand |
| Inventory | -36.59 Million | -9.41 Million | -9.7 Million | -7.57 Million | -299 Thousand | 648 Thousand |
| Other working capital | 29.62 Million | 2.84 Million | 2.16 Million | 3.51 Million | 4.02 Million | -1.9 Million |
| Cash at beginning of period | 20.75 Million | 25.4 Million | 12.57 Million | 11.66 Million | 6 Million | 6.51 Million |
| Cash at end of period | 22.28 Million | 20.75 Million | 25.4 Million | 12.59 Million | 11.66 Million | 6 Million |
| Capital Expenditure | -1.79 Million | -2.15 Million | -1.99 Million | -668 Thousand | -605 Thousand | -1.12 Million |
| Effect of forex changes on cash | 4000.00 | 63 Thousand | -65 Thousand | - | 6 Million | - |
| Net cash flow / Change in cash | 1.52 Million | -4.64 Million | 12.82 Million | 929 Thousand | 5.65 Million | -510 Thousand |
| Free Cash Flow | 21.57 Million | 5.26 Million | 9.19 Million | 9.62 Million | 9.53 Million | 746 Thousand |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 12.81 Million | 22.36 Million | 9.54 Million | 4.77 Million | 16.07 Million | 8.05 Million |
| Depreciation & Amortization | 3.35 Million | 5.81 Million | 2.46 Million | 1.23 Million | 4.36 Million | 2.51 Million |
| Deferred income taxes | - | - | - | - | -25.88 Million | 3.14 Million |
| Stock-based compensation | - | - | - | - | 419 Thousand | 209.5 Thousand |
| Change in working capital | - | -6.93 Million | - | - | -13.87 Million | -7.28 Million |
| Other non-cash items | 11.66 Million | 50.29 Million | -4.84 Million | -4.88 Million | 26.31 Million | 600 Thousand |
| Investing Cash Flow | -95.76 Million | -104.85 Million | -9.09 Million | -4.54 Million | -2.1 Million | -1.08 Million |
| Investments in PPE | -729 Thousand | -1.7 Million | -972 Thousand | -486 Thousand | -2.15 Million | -1.12 Million |
| Acquisitions | -91.42 Million | -99.54 Million | -8.12 Million | -4.13 Million | 57 Thousand | 33 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -3.6 Million | -3.6 Million | 73.5 Thousand | 73.5 Thousand | 57 Thousand | 16.5 Thousand |
| Financing Cash Flow | 26.36 Million | 83.01 Million | 56.64 Million | 28.32 Million | -10.02 Million | -5.61 Million |
| Debt repayment | -31.1 Million | -31.1 Million | - | - | -2.86 Million | - |
| Dividends payments | -4.75 Million | -8.82 Million | -4.07 Million | -2.03 Million | -7.16 Million | -3.97 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.68 Million | 65 Million | 62.32 Million | - | - | - |
| Other Financing Activities | -2.65 Million | - | 30.35 Million | 30.35 Million | -2.86 Million | -821 Thousand |
| Accounts receivables | - | -25.74 Million | - | - | -7.36 Million | -3.68 Million |
| Accounts payables | - | 25.78 Million | - | - | 56 Thousand | - |
| Inventory | - | -36.59 Million | - | - | -9.41 Million | -4.7 Million |
| Other working capital | - | 29.62 Million | - | - | 2.84 Million | 1.1 Million |
| Cash at beginning of period | 70.49 Million | 20.75 Million | 20.75 Million | - | 25.4 Million | 21.25 Million |
| Cash at end of period | 22.28 Million | 22.28 Million | 70.49 Million | 24.86 Million | 20.75 Million | 20.75 Million |
| Capital Expenditure | -729 Thousand | -1.7 Million | -972 Thousand | -486 Thousand | -2.15 Million | -1.12 Million |
| Effect of forex changes on cash | - | - | -25 Thousand | -25 Thousand | 63 Thousand | 31 Thousand |
| Net cash flow / Change in cash | -48.2 Million | 1.52 Million | 49.73 Million | 24.86 Million | -4.64 Million | -501 Thousand |
| Free Cash Flow | 20.4 Million | 21.66 Million | 1.26 Million | 631.5 Thousand | 5.26 Million | 5.01 Million |
CIP
FCL
3037
MANGLMCEM
VVV3
LPSB3